People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MedShape Solutions, Inc. | — | Biotechnology | Series A | $31.4M | $25.3M | 2009 |
James Kurt Jacobus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Kurt Jacobus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Niles L. Noblitt | 1 | 3 |
| Niles Noblitt | 1 | 3 |
| Thomas E. Hills | 1 | 2 |
| Jack R. Blair | 1 | 2 |
| Jack Blair | 1 | 2 |
| Richard H. Leach | 1 | 1 |
| Jack C. Griffis | 1 | 1 |
| Becky J. Brown | 1 | 1 |
| Gregory S. Dane | 1 | 1 |
| Lutz J. Biedermann | 1 | 1 |
| Paul F. Hills | 1 | 1 |
| Kenneth A. Gall | 1 | 1 |
| Douglas J. Pacaccio | 1 | 1 |
| James J. Lorenzo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.